| AquaBounty Technologies is engaged in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. Co. is conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. Co.'s primary product is the AquAdvantage Salmon. Co. has obtained the licensing rights for a gene construct used to create a breed of farm-raised Atlantic salmon. Co. has approval for the production and sale of its AquAdvantage Salmon (GE Atlantic salmon) product in the U.S. In addition, Co. has approval from Health Canada for the sale of its GE Atlantic salmon product in Canada. The AQB average annual return since 2017 is shown above.
The Average Annual Return on the AQB average annual return since 2017 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether AQB average annual return since 2017 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the AQB average annual return calculation with any dividends reinvested as applicable (on ex-dates).